Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

22,021 public trials 3,763 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)

NCT06551246

Conditions
Behavior, Behavioral Symptoms, Diurnal Enuresis, +17 more
Locations
  • Department of Pediatric and Adolescent Medicine, Aalborg University Hospital Aalborg, Denmark
  • Department of Pediatric and Adolescent Medicine, Aarhus University Hospital Aarhus, Aarhus N, Denmark
  • Department of Pediatric and Adolescent medicine, Esbjerg Hospital Esbjerg, Denmark
  • Department of Pediatric and Adolescent Medicine, Gødstrup Hospital Herning, Denmark
View Trial Details
Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

NCT06026410

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
Locations
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 38 locations
View Trial Details
Recruiting

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

NCT06480227

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +13 more
Locations
  • University of California at San Diego La Jolla, California, United States
  • Kaiser Permanente -- San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery Durham, North Carolina, United States
View Trial Details
Recruiting

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

NCT04890613

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +26 more
Locations
  • University of California, Los Angeles Santa Monica, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Hospital Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions